Branded Generics Market: Oncology Therapeutic Application Segment Expected to Grow Significantly in Developed Markets over the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016 –2026

  • Published: Jan, 2017
  • Report Code: REP-GB-1260

An Incisive, In-depth Analysis on the Branded Generics Market

This study offers a comprehensive, 360 degree analysis on the Branded Generics market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Branded Generics market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Increasing prevalence of chronic and lifestyle diseases expected to create demand for branded generics over the assessment period

The global branded generics market size was valued at more than US$ 190 Bn in 2015 and is expected to witness a 7.3% CAGR over the forecast period (2016–2026). The market is projected to be valued at more than US$ 410 Bn by 2026. The global branded generics market is expected to represent incremental opportunity of nearly US$ 220 Bn between 2016 and 2026. Rising number of comorbidities like diabetes and cardiovascular diseases is creating ample opportunities for new and existing players in the global branded generics market.

Global Branded Generics Market Value (US$ Bn) By Therapeutic Application, 2016-2026

Cardiovascular diseases application segment expected to hold a large market revenue share over the projected period

The cardiovascular diseases segment was estimated to account for 11.8% market share of the global branded generics market by 2016 end and is expected to gain 102 BPS by 2026 over 2016. Cardiovascular diseases segment is expected to register high Y-o-Y growth throughout the forecast period. The segment was expected to reach a value of nearly US$ 25 Bn by 2016 end and is projected to remain the dominant segment during the forecast period. The dermatology diseases segment is expected to register moderate Y-o-Y growth as compared to other segments throughout the forecast period. Revenue contribution of this segment to the global branded generics market is expected to increase at a CAGR of 6.0% over the forecast period. In terms of value, the cardiovascular diseases segment is expected to register the highest CAGR of 8.2% during the assessment period. The neurology and dermatology diseases segments are expected to remain the least attractive segments in the global branded generics market in revenue terms with an attractive index of 0.5 each over the forecast period.

Diabetes segment market revenue share projected to grow at a significant CAGR owing to increasing prevalence of diabetes in Asia Pacific and MEA regions

The Diabetes segment is estimated to create absolute $ opportunity of US$ 1.6 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 7.7% from 2016 to 2026 to reach a value of nearly US$ 45 Bn by 2026. The Oncology segment is estimated to create absolute $ opportunity of US$ 1.1 Bn in 2017 over 2016. Revenue from this segment is projected to exhibit a CAGR of 6.9% from 2016 to 2026 to reach a value of more than US$ 30 Bn by 2026. The Neurology segment is estimated to create absolute $ opportunity of US$ 0.8 Bn in 2017 over 2016. Revenue from this segment is projected to register a CAGR of 6.1% from 2016 to 2026 to reach a value of about US$ 25.0 Bn by 2026. The Analgesics and Anti-inflammatory segment is estimated to create absolute $ opportunity of US$ 0.9 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 6.6% from 2016 to 2026 to reach a value of nearly US$ 30 Bn by 2026.

branded generics market_Image for preview analysis

Increasing out-of-pocket healthcare expenditure and patent expiries of blockbuster drugs fuelling the global branded generics market

As per Future Market Insights analysis, Branded Generics in the Emerging Markets such as Brazil, Russia, India and China are the most lucrative markets for branded generics. A big aspect that is fuelling the global branded generics market is the increasing out-of-pocket expenditure on healthcare in both emerging and developed economies. In addition, patent expiries of blockbuster drugs is also positively impacting the global branded generics market growth. Analysts working on this report have noticed a trend of mergers and acquisitions amongst the key market players to help consolidate their position in the global branded generics market. 

Future Market Insights recently published an insightful market research report providing an in-depth overview of the branded generics market highlighting the parameters influencing the market during the forecast period 2016-2026. With a complete assessment of the branded generics market, this research report showcases the growth opportunities of the market by providing extensive information related to the various factors of the branded generics market. Future Market Insights have covered major market aspects and provided a wider picture of the branded generics market, by tracing key aspects such as trends, opportunities, market drivers and restraints pertaining to the market.

Extensive Impact Analysis of the Branded Generics Market

The report offers a complete analysis of the branded generics market with a focus on various aspects related to the market. The extensive impact analysis of the market provides a comprehensive understanding of the global market influencers and the exclusive inclusion of impact analysis of the growth driver and restraints helps clients and key players in decision-making and succession planning pertaining to the future prospects for the branded generics market significantly.

With a closer peek into the market the report examines various aspects that illustrate the current market scenario including an overview of the demand for branded generics and a region-wise analysis to understand the global scenario of the branded generics market. With an illustrative future outlook of the market, the report significantly covers various future prospects for the branded generics market that could fuel the growth of the market in the forecast period.

Market Dynamics Shaping the Future of the Market

The report utilizes a broader approach to mention the global branded generics market landscape, ensuring complete coverage of the market dynamics contributing to the branded generics market as a whole. The value-added insights related to the macroeconomic factors, supply and demand side drivers, expansion and growth opportunities, market trends as well as restraints impacting the market adversely are included in the report.

The global market trends and opportunities for the branded generics market are the key takeaways of the publication with a detailed understanding of the how the new advancements and developments witnessed by the market are shaping the future of the market. The analysis of the key market players and manufacturers round the globe and their shift towards a strategic approach are highlighting the market scenario in the future.

Competitive Analysis for Understanding Competitive Landscape of the Market

The report provides a thorough information of the competitive landscape with the help of competitive analysis model, to help established players and new entrants in strategic decision making. With an extensive market study regarding the competitive landscape, the report examines the market capabilities with an in-depth regional segmentation and market value differentiated by region.

The tables and figures give a detailed outlook of the market scenario for the market players and their current as well as forecasted positions in the market throughout the forecast period. A unique dashboard of the competitive landscape highlights the challenges, opportunities and strategic actions carried out by global branded generics market leaders, helping the new entrants understand the market better. With the inclusion of SWOT analysis for each key player explicitly, along with their major developments and a strategic overview featured in the branded generics market, the report serves as a great industry analysis tool.

Segmentation and Differentiation

The report gives a brief introduction to the branded generics market and the segmentation of the market by formulation type, therapeutic application, drug class, distribution channel, and region. The research study ensures a complete understanding for the reader in terms of market segmentation. With a thorough analysis of the branded generics market on the basis of drug class and therapeutic application differentiation, the report provides a revenue forecast for the forecasted period. Similarly, it presents forecast in terms of value for formulation type, distribution channel, and regional segmentation.

Research Methodology

With an extensive primary and secondary research conducted to understand the global branded generics market scenario, analysts at Future Market Insights have carried out research with a systematic approach. The forecast presented in the report highlights actual data pertaining to the current scenario along with the data provided for the forecasted period to understand the dynamically changing branded generics market. With in-depth and detailed data analysis the report provides key information for the reader for gaining a competitive edge in the branded generics market.

Branded Generics Market Reports - Table of Contents

Branded Generics Market Reports - List of Tables

Table 1: Global Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026

Table 2: Global Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 3: Global Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 4: Global Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 5: Global Branded Generics Market Value (US$ Bn) Analysis and Forecast By Region, 2015–2026

Table 6: North America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2026

Table 7: North America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026

Table 8: North America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 9: North America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 10: North America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 11: Latin America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2026

Table 12: Latin America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026i

Table 13: Latin America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 14: Latin America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 15: Latin America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 16: Western Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2026

Table 17: Western Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026

Table 18: Western Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 19: Western Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 20: Western Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 21: Eastern Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2026

Table 22: Eastern Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026

Table 23: Eastern Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 24: Eastern America Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 25: Eastern Europe Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 26: APEJ Branded Generics Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2026

Table 27: APEJ Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026

Table 28: APEJ Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 29: APEJ Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 30: APEJ Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 31: Japan Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026

Table 32: Japan Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 33: Japan Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 34: Japan Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Table 35: MEA Branded Generics Market Value (US$ Bn) Analysis and Forecast By Country, 2015–2026

Table 36: MEA Branded Generics Market Value (US$ Bn) Analysis and Forecast By Therapeutic Application, 2015 – 2026

Table 37: MEA Branded Generics Market Value (US$ Bn) Analysis and Forecast By Drug Class, 2015 – 2026

Table 38: MEA Branded Generics Market Value (US$ Bn) Analysis and Forecast By Formulation Type, 2015 – 2026

Table 39: MEA Branded Generics Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015–2026

Branded Generics Market Reports - List of Figures

Figure 01: Global Branded Generics Market Value Share By, Therapeutic Application, 2016

Figure 02: Global Branded Generics Market Value Share By, Formulation Type, 2016

Figure 03: Global Branded Generics Market Value Share By, Distribution Channel, 2016

Figure 04: Global Branded Generics Market Value Share By, Region, 2016

Figure 05: Global Branded Generics Market Value (US$ Bn) Forecast, 2015–2026 

Figure 06: Global Branded Generics Market Absolute $ Opportunity, 2015–2026 

Figure 07: Global Branded Generics Market Y-o-Y Growth, 2015–2026 

Figure 8: Global Branded Generics Market Share Analysis (%) By Therapeutic Application, 2016 & 2026

Figure 9: Global Branded Generics Market Y-o-Y Growth (%) By Therapeutic Application, 2015–2026 

Figure 10: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Oncology Segment, 2015 – 2026

Figure 11: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Cardiovascular Diseases Segment, 2015 – 2026

Figure 12: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Diabetes Segment, 2015 – 2026

Figure 13: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Neurology Segment, 2015 – 2026

Figure 14: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Gastrointestinal Diseases Segment, 2015 – 2026

Figure 15: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Dermatology Diseases Segment, 2015 – 2026

Figure 16: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Analgesics and Anti-inflammatory Segment, 2015 – 2026

Figure 17: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Others Segment, 2015 – 2026

Figure 18: Global Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016–2026 

Figure 19: Global Branded Generics Market Share Analysis (%) By Drug Class, 2020 & 2026

Figure 20: Global Branded Generics Market Y-o-Y Growth (%) By Drug Class, 2015–2026 

Figure 21: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Alkylating Agents Segment, 2015 – 2026

Figure 22: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Antimetabolites Segment, 2015 – 2026

Figure 23: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Hormones Segment, 2015 – 2026

Figure 24: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Anti-Hypertensive  Segment, 2015 – 2026

Figure 25: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Lipid Lowering Drugs Segment, 2015 – 2026

Figure 26: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Anti-Depressants Segment, 2015 – 2026

Figure 27: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Anti-Psychotics Segment, 2015 – 2026

Figure 28: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Anti-Epileptics Segment, 2015 – 2026

Figure 29: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Others Segment, 2015 – 2026

Figure 30: Global Branded Generics Market Attractiveness Analysis By Drug Class, 2016–2026 

Figure 31: Global Branded Generics Market Share Analysis (%) By Formulation Type, 2020 & 2026

Figure 32: Global Branded Generics Market Y-o-Y Growth (%) By Formulation Type, 2015–2026 

Figure 33: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Oral Segment, 2015 – 2026

Figure 34: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Parenteral Segment, 2015 – 2026

Figure 35: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Topical

Figure 36: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Others Segment, 2015 – 2026

Figure 37: Global Branded Generics Market Attractiveness Analysis By Formulation Type, 2016–2026 

Figure 38: Global Branded Generics Market Share Analysis (%) By Distribution Channel, 2016, 2026

Figure 39: Global Branded Generics Market Y-o-Y Growth (%) By Distribution Channel, 2015–2026 

Figure 40: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Hospital Pharmacies Segment, 2015 – 2026

Figure 41: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Retail Pharmacies Segment, 2015 – 2026

Figure 42: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Online Pharmacies Segment, 2015 – 2026

Figure 43: Global Branded Generics Market Absolute $ Opportunity (US$ Bn) By Drug Stores Segment, 2015 – 2026

Figure 44: Global Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016–2026 

Figure 45: Global Branded Generics Market Share Analysis (%) By Region, 2016, 2026

Figure 46: Global Branded Generics Market Y-o-Y Growth (%) By Region, 2015–2026 

Figure 47: North America Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 48: Latin America Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 49: Western Europe Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 50: Eastern Europe Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 51: APEJ Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 52: Japan Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 53: MEA Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 54: Global Branded Generics Market Attractiveness Analysis By Region, 2016–2026 

Figure 55: North America Branded Generics Market Share Analysis (%) By Country, 2016, 2026

Figure 56: North America Branded Generics Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 57: The U.S. Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 58: Canada Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 59: North America Branded Generics Market Attractiveness Analysis By Country, 2016 – 2026 

Figure 60: North America Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016 – 2026 

Figure 61: North America Branded Generics Market Attractiveness Analysis By Drug Class, 2016 – 2026 

Figure 62: North America Branded Generics Market Attractiveness Analysis By Formulation Type, 2016 – 2026 

Figure 63: North America Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016 – 2026 

Figure 64: Latin America Branded Generics Market Share Analysis (%) By Country, 2016, 2020 & 2026

Figure 65: Latin America Branded Generics Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 66: Mexico Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 67: Brazil Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 68: Argentina Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 69: Rest of Latin America

Figure 70: Latin America Branded Generics Market Attractiveness Analysis By Country, 2016 – 2026 

Figure 71: Latin America Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016 – 2026 

Figure 72: Latin America Branded Generics Market Attractiveness Analysis By Drug Class, 2016 – 2026 

Figure 73: Latin America Branded Generics Market Attractiveness Analysis By Formulation Type, 2016 – 2026 

Figure 74: Latin America Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016 – 2026 

Figure 75: Western Europe Branded Generics Market Share Analysis (%) By Country, 2016, 2026

Figure 76: Western Europe Branded Generics Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 77: Germany Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 78: France Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 79: The U.K. Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 80: Spain Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 81: Italy Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 82: Nordic Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 83: BENELUX Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 84: Rest of Western Europe Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 85: Western Europe Branded Generics Market Attractiveness Analysis By Country, 2016 – 2026 

Figure 86: Western Europe Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016 – 2026 

Figure 87: Western Europe Branded Generics Market Attractiveness Analysis By Drug Class, 2016 – 2026 

Figure 88: Western Europe Branded Generics Market Attractiveness Analysis By Formulation Type, 2016 – 2026 

Figure 89: Western Europe Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016 – 2026 

Figure 90: Eastern Europe Branded Generics Market Share Analysis (%) By Country, 2016, 2026

Figure 91: Eastern Europe Branded Generics Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 92: Russia Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 93: Poland Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 94: Rest of Eastern Europe Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 95: Eastern Europe Branded Generics Market Attractiveness Analysis By Country, 2016 – 2026 

Figure 96: Eastern Europe Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016 – 2026 

Figure 97: Eastern Europe Branded Generics Market Attractiveness Analysis By Drug Class, 2016 – 2026 

Figure 98: Eastern Europe Branded Generics Market Attractiveness Analysis By Formulation Type, 2016 – 2026 

Figure 99: Eastern Europe Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016 – 2026 

Figure 100: APEJ Branded Generics Market Share Analysis (%) By Country, 2016,  2026

Figure 101: APEJ Branded Generics Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 102: China Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 103: India Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 104: ASEAN Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 105: A&NZ Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 106: Rest of APEJ Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 107: APEJ Branded Generics Market Attractiveness Analysis By Country, 2016 – 2026 

Figure 108: APEJ Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016 – 2026 

Figure 109: APEJ Branded Generics Market Attractiveness Analysis By Drug Class, 2016 – 2026 

Figure 110: APEJ Branded Generics Market Attractiveness Analysis By Formulation Type, 2016 – 2026 

Figure 111: APEJ Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016 – 2026 

Figure 112: Japan Branded Generics Market Attractiveness Analysis By Drug Class, 2016 – 2026 

Figure 113: Japan Branded Generics Market Attractiveness Analysis By Formulation Type, 2016 – 2026 

Figure 114: Japan Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016 – 2026 

Figure 115: Japan Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016 – 2026 

Figure 116: MEA Branded Generics Market Share Analysis (%) By Country, 2016, 2026

Figure 117: MEA Branded Generics Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 118: GCC countries Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 119: South Africa Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 120: North Africa Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 121: Rest of MEA Branded Generics Market Absolute $ Opportunity (US$ Bn), 2015 – 2026

Figure 122: MEA Branded Generics Market Attractiveness Analysis By Country, 2016 – 2026 

Figure 123: MEA Branded Generics Market Attractiveness Analysis By Therapeutic Application, 2016 – 2026 

Figure 125: MEA Branded Generics Market Attractiveness Analysis By Formulation Type, 2016 – 2026 

Figure 124: MEA Branded Generics Market Attractiveness Analysis By Drug Class, 2016 – 2026 

Figure 126: MEA Branded Generics Market Attractiveness Analysis By Distribution Channel, 2016 – 2026 

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology